# Mark J. O’Connor

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-j-o-connor/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,795 |
| Field | PARP inhibition in cancer therapy |
| h-index | 69 |
| i10-index | 106 |
| Last Known Institution | AstraZeneca (United Kingdom) |
| OpenAlex ID | https://openalex.org/A5058717267 |
| ORCID iD | https://orcid.org/0000-0003-1823-625X |
| Works | 449 |

## Researcher papers

- [Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers](https://scholariq.org/papers/inhibition-of-poly-adp-ribose-polymerase-in-tumors-from-i-brca-i-mutation/)
- [Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action](https://scholariq.org/papers/laying-a-trap-to-kill-cancer-cells-parp-inhibitors-and-their-mechanisms-of/)
- [A Biobank of Breast Cancer Explants with Preserved Intra-tumor Heterogeneity to Screen Anticancer Compounds](https://scholariq.org/papers/a-biobank-of-breast-cancer-explants-with-preserved-intra-tumor-heterogeneity-to/)
- [Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition](https://scholariq.org/papers/mild-hyperthermia-inhibits-homologous-recombination-induces-brca2-degradation/)

## Researcher topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [DNA Repair Mechanisms](https://scholariq.org/topics/dna-repair-mechanisms/)
- [Computational Drug Discovery Methods](https://scholariq.org/topics/computational-drug-discovery-methods/)
- [CRISPR and Genetic Engineering](https://scholariq.org/topics/crispr-and-genetic-engineering/)
- [Cancer-related Molecular Pathways](https://scholariq.org/topics/cancer-related-molecular-pathways/)

## Researcher university

- [AstraZeneca (United Kingdom)](https://scholariq.org/institutions/astrazeneca-united-kingdom/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.